Yahoo Web Search

Search results

1. • 

     Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks

     Bloomberg via Yahoo Finance· 19 hours ago

     (Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...

2. • 

     Vaccine makers receive stock boost after third human bird flu case in US

     Newsweek· 2 hours ago

     Shares in some companies that produce vaccines have seen stock boosts following a small number of...

3. • 

     The Highest Paid CEOs of 2023

     The Wall Street Journal· 2 days ago

     Moderna reported total pay of $17.1 million for CEO Stéphane Bancel last year, including $12.5 million in stock and option awards. The value of those...

4. • 

     Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)

     Benzinga· 1 day ago

     On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...

5. • 

     Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay

     Barrons.com· 3 days ago

     Sales of Pfizer Moderna, and Novavax shots fell far below expectations last year, setting off steep ...

6. • Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)

     ETF DAILY NEWS· 2 days ago

     Robeco Institutional Asset Management B.V. lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most ...

7. • 

     Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe

     Reuters via Yahoo News· 6 days ago

     The company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...

8. • 

     Could Novavax Become the Next Moderna?

     The Motley Fool via AOL· 6 days ago

     Moderna fared well, dominating the vaccine market along with big pharma rival Pfizer, and bringing in as much as $18 billion in annual vaccine revenue....

9. • 

     European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

     Benzinga via Yahoo Finance· 6 days ago

     Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...

10. • NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)

      ETF DAILY NEWS· 6 days ago

      The fund owned 1,222 shares of the company’s stock after purchasing an additional 205 shares during the period. NBC Securities Inc.’s holdings in Moderna